dacarbazine has been researched along with Acute Liver Injury, Drug-Induced in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (19.57) | 18.7374 |
1990's | 3 (6.52) | 18.2507 |
2000's | 3 (6.52) | 29.6817 |
2010's | 31 (67.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Efferth, T; Giordano, FA; Krishna, S; Schmiedek, P; Schöttler, U; Wenz, F | 2 |
Deitz, AC; Desai, VCA; He, J; Holick, CN; Lanes, S; Quinlan, SC | 1 |
Kleiner, DE | 1 |
Eslami, A; Jha, KK; Mathur, AD; Wang, H | 1 |
Becker, F; Fietkau, R; Hecht, M; Schmidtner, J; Semrau, S | 1 |
Egle, A; Greil, R; Grundbichler, M; Hufnagl, C; Magnes, T; Melchardt, T; Moik, M; Strasser, M; Weiss, L | 1 |
Kolarović, J; Lalić-Popović, M; Lalošević, D; Mikov, M; Milijašević, B; Stefanović, D; Tomić, Z | 1 |
Adeyi, O; Fung, S; Mason, M; Millar, BA | 1 |
Balducci, N; Biolato, M; Di Napoli, N; Diletto, B; Grieco, A; Miele, L; Tafuri, MA; Vecchio, FM | 1 |
Fukushima, S; Kiyohara, Y; Namikawa, K; Okuyama, R; Otsuka, Y; Shibagaki, N; Tokudome, T; Tsutsumida, A; Uchi, H; Uhara, H; Yamazaki, N | 1 |
Baretti, M; Di Tommaso, L; Santoro, A; Simonelli, M | 1 |
Lee, TY; Lu, H; Sheng, R; Zhang, C | 1 |
Abu Rmeileh, A; Benson, AA; Chen, S; Cohen, J; Daher, S; Khoury, T; Mizrahi, M; Yaari, S | 1 |
Hoorens, A; Neyns, B; Stupp, R | 1 |
Bedikian, AY; Cain, S; Glass, MR; Homsi, J; Hwu, P; Hwu, WJ; Kim, KB; Papadopoulos, NE; Rudewicz, P; Vernillet, L | 1 |
Egawa, T; Horiguchi, M; Kaji, H; Kim, J; Koyanagi, S; Makino, K; Matsunaga, N; Ohdo, S | 1 |
Buesa, JM; Carrasco, JA; Casado, A; Cruz, J; Cubedo, R; de Andrés, R; De Juan, A; Fra, J; García-Del-Muro, X; Gómez-España, A; Laínez, N; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Meana, A; Pericay, C; Poveda, A; Rubió, J | 1 |
Afzal, P; Campbell, AP; Dixit, S; Hingorani, M | 1 |
Bronder, E; Garbe, E; Herbst, H; Kauffmann, W; Klimpel, A; Orzechowski, HD; Sarganas, G; Thomae, M | 1 |
Mohammad Alizadeh, A; Zamani, N | 1 |
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N | 1 |
Conjeevaram, HS; Grant, LM; Kleiner, DE; Lee, WM; Vuppalanchi, R | 1 |
Hong, YK; Jeun, SS; Kang, JK; Kim, MC; Kim, MK; Lee, KS; Lee, TK; Park, CK; Yang, SH | 1 |
Czarnetzki, BM; Macher, E | 1 |
Doepfmer, K; Féaux de Lacroix, W; Groth, W; Hauk, H; Runne, U; Wacker, D | 1 |
Classen, M; Dancygier, H; Leuschner, U; Milbradt, R; Runne, U | 1 |
Caselitz, J; Jänner, M; Voigt, H | 1 |
Arseneau, JC; Asbury, RF; Descalzi, ME; Ratcliffe, RL; Rosenthal, SN | 1 |
Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
Braun, S; Heine, M; Paschke, R; Usadel, KH | 1 |
Bouche, O; Cartier, H; Egreteau, JP; Lambolais, C; Quinio, P; Savry, C | 1 |
Colsky, J; Costanza, ME; Cunningham, T; Nathanson, L; Regelson, W; Schoenfeld, D; Sedransk, N; Wolter, J | 1 |
Czarnetzki, BM; Frosch, PJ; Gottschalk, I; Grundmann, E; Macher, E | 1 |
Lusch, CJ; Mastrangelo, MJ; McClay, E | 1 |
Heine, M; Paschke, R | 1 |
6 review(s) available for dacarbazine and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recent Advances in the Histopathology of Drug-Induced Liver Injury.
Topics: Antineoplastic Agents, Alkylating; Biopsy; Chemical and Drug Induced Liver Injury; Dacarbazine; Diagnosis, Differential; Dietary Supplements; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Phytotherapy; Temozolomide | 2018 |
Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Fatal Outcome; Glioblastoma; Humans; Male; Temozolomide | 2015 |
Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Chemical and Drug Induced Liver Injury; Chemoradiotherapy; Dacarbazine; Drugs, Chinese Herbal; Female; Glioblastoma; Humans; Temozolomide | 2017 |
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Glioblastoma; Hepatitis; Humans; Male; Middle Aged; Prognosis; Temozolomide; United States; United States Food and Drug Administration | 2012 |
Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Chemical and Drug Induced Liver Injury; Dacarbazine; Female; Humans; Liver; Male; Middle Aged; Temozolomide | 2013 |
6 trial(s) available for dacarbazine and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma.
Topics: Adult; Aged; Alanine Transaminase; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; CTLA-4 Antigen; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Eruptions; Endocrine System Diseases; Female; Humans; Immunosuppressive Agents; Ipilimumab; Japan; Kaplan-Meier Estimate; Maintenance Chemotherapy; Male; Melanoma; Middle Aged; Neoplasm Proteins; Remission Induction; Treatment Outcome | 2015 |
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Dacarbazine; DNA Mismatch Repair; Drug Administration Schedule; Female; Humans; Indoles; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Temozolomide | 2009 |
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Diseases; Gemcitabine; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Spain; Treatment Outcome; Young Adult | 2011 |
Temozolomide chemotherapy in patients with recurrent malignant gliomas.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Glioma; Humans; Leukopenia; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Survival Analysis; Temozolomide; Treatment Outcome; Vomiting | 2006 |
Randomized study for the treatment of adult advanced Hodgkin's disease: epirubicin, vinblastine, bleomycin, and dacarbazine (EVBD) versus mitoxantrone, vinblastine, bleomycin, and dacarbazine (MVBD).
Topics: Actuarial Analysis; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Liver Injury; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; Prospective Studies; Thrombocytopenia; Treatment Outcome; Ventricular Function, Left; Vinblastine | 1994 |
Results with methyl-CCNU and DTIC in metastatic melanoma.
Topics: Brain Neoplasms; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Male; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Prognosis; Remission, Spontaneous; Semustine; Thrombocytopenia; Time Factors; Triazenes | 1977 |
34 other study(ies) available for dacarbazine and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Answer to the comment of Hai Lu et al. regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report and review of the literature. Arch Toxicol (2016)".
Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide | 2017 |
Risk of severe acute liver injury among patients with brain cancer treated with temozolomide: a nested case-control study using the healthcore integrated research database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Case-Control Studies; Chemical and Drug Induced Liver Injury; Cohort Studies; Dacarbazine; Databases, Factual; Delivery of Health Care; Disease-Free Survival; Female; Glioblastoma; Humans; Male; Middle Aged; Temozolomide; Young Adult | 2017 |
Acute liver failure secondary to ABVD use.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Chemical and Drug Induced Liver Injury; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoconjugates; Syncope; Treatment Outcome; Vinblastine | 2018 |
Temozolomide-induced liver damage. A case report.
Topics: Antineoplastic Agents, Alkylating; Chemical and Drug Induced Liver Injury; Dacarbazine; Diagnosis, Differential; Female; Humans; Middle Aged; Temozolomide; Treatment Outcome | 2014 |
Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Bevacizumab; Brain Neoplasms; Camptothecin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Dacarbazine; Disease Progression; Drugs, Chinese Herbal; Female; Glioblastoma; Herb-Drug Interactions; Humans; Irinotecan; Liver; Middle Aged; Phytotherapy; Temozolomide | 2014 |
Acute toxic effects of single dose dacarbazine: hematological and histological changes in an animal model.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cricetinae; Dacarbazine; Dose-Response Relationship, Drug; Fibrosarcoma; Hematologic Diseases; Hepatitis; Humans; Male; Pneumonia; Treatment Outcome | 2014 |
Temozolomide: fatal hepatic failure.
Topics: Antineoplastic Agents, Alkylating; Chemical and Drug Induced Liver Injury; Dacarbazine; Humans; Liver Failure; Liver Function Tests; Risk Assessment; Risk Factors; Temozolomide; Time Factors | 2014 |
Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Biopsy, Needle; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestyramine Resin; Common Bile Duct Diseases; Dacarbazine; Female; Follow-Up Studies; Glioblastoma; Humans; Immunohistochemistry; Jaundice; Liver Function Tests; Middle Aged; Syndrome; Temozolomide; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Autoimmunity; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Neoplasm Staging; Nivolumab; Programmed Cell Death 1 Receptor; Temozolomide; Tumor Suppressor Proteins | 2016 |
Comments regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature".
Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide | 2017 |
Acute liver injury induced by levetiracetam and temozolomide co-treatment.
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Case-Control Studies; Chemical and Drug Induced Liver Injury; Dacarbazine; Drug Therapy, Combination; Female; Humans; Israel; Levetiracetam; Liver Function Tests; Male; Middle Aged; Multivariate Analysis; Piracetam; Regression Analysis; Retrospective Studies; Temozolomide | 2017 |
Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Cholestasis; Dacarbazine; Glioblastoma; Humans; Liver Failure; Male; Middle Aged; Temozolomide; Valproic Acid | 2008 |
Glucocorticoid-dependent expression of O(6)-methylguanine-DNA methyltransferase gene modulates dacarbazine-induced hepatotoxicity in mice.
Topics: Adrenalectomy; Animals; Antineoplastic Agents; Cells, Cultured; Chemical and Drug Induced Liver Injury; Circadian Rhythm; Corticosterone; Dacarbazine; Dose-Response Relationship, Drug; Glucocorticoids; Hormone Antagonists; Male; Mice; Mice, Inbred ICR; Mifepristone; O(6)-Methylguanine-DNA Methyltransferase; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Temozolomide induced liver injury.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Chemoradiotherapy; Dacarbazine; Female; Glioblastoma; Humans; Middle Aged; Temozolomide | 2011 |
Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antineoplastic Agents, Alkylating; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Drug Therapy, Combination; Glioblastoma; Humans; Male; Middle Aged; Prognosis; Temozolomide | 2012 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2013 |
DTIC (dacarbazine)-induced hepatic damage. Possible pathogenesis and prevention.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dacarbazine; Female; gamma-Glutamyltransferase; Humans; Melanoma; Prednisone; Skin Neoplasms | 1981 |
Acute liver dystrophy with thrombosis of hepatic veins: a fatal complication of dacarbazine treatment.
Topics: Chemical and Drug Induced Liver Injury; Dacarbazine; Female; Hepatic Veins; Humans; Liver Diseases; Male; Melanoma; Middle Aged; Necrosis; Skin Neoplasms; Thrombosis | 1983 |
Dacarbazine (DTIC)-induced human liver damage light and electron-microscopic findings.
Topics: Chemical and Drug Induced Liver Injury; Dacarbazine; Humans; Liver; Liver Diseases; Male; Middle Aged | 1983 |
[Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].
Topics: Aged; Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Dacarbazine; Hepatic Veins; Humans; Liver; Lymphatic Metastasis; Male; Melanoma; Skin Neoplasms | 1981 |
Hepatic veno-occlusive disease due to DTIC.
Topics: Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Dacarbazine; Humans; Liver; Male; Melanoma; Middle Aged; Necrosis | 1980 |
Mechanisms of hepatotoxicity caused by dacarbazine in rats.
Topics: Alanine Transaminase; Animals; Blood Platelets; Chemical and Drug Induced Liver Injury; Cholinesterases; Dacarbazine; Enzyme Induction; Leukocytes; Liver; Liver Diseases; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 1993 |
Fatal hepatic toxicity of DTIC: a new case.
Topics: Chemical and Drug Induced Liver Injury; Dacarbazine; Fatal Outcome; Female; Humans; Melanoma; Middle Aged | 1997 |
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
Topics: Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Dacarbazine; Drug Hypersensitivity; Eosinophils; Female; Humans; Liver Diseases; Melanoma; Middle Aged; Skin Neoplasms | 1979 |
Allergy-induced hepatic toxicity associated with dacarbazine.
Topics: Autopsy; Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Dacarbazine; Drug Hypersensitivity; Humans; Laparotomy; Liver Diseases; Male; Melanoma; Middle Aged; Skin Diseases | 1987 |
Pathophysiological aspects of dacarbazine-induced human liver damage.
Topics: Adult; Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Dacarbazine; Eosinophilia; Female; Humans; Liver | 1985 |